title: Significant response to oral Etoposide in the treatment of an unresectable cardiac sarcoma.
abstract: Primary cardiac sarcomas are rare and carry a poor prognosis. The standard of care is complete resection. Outcomes for patients without complete resection are dismal, and the benefit of adjuvant therapy is uncertain. A 9-year-old girl presented with a large right-sided cardiac mass. After biopsy, the tumor was classified as an undifferentiated sarcoma. Resection was not feasible due to apparent invasion of the right ventricle and atrioventricular groove. Treatment with oral etoposide resulted in a 97% reduction in tumor volume and allowed for complete resection of residual tumor. She is alive with no evidence of disease 25 months from diagnosis.
authors: *Department of Pediatrics, Division of Hematology-Oncology-BMT †Department of Pediatrics, Division of Cardiology ‡Department of Surgery, Division of Pediatric Surgery §Department of Pathology ∥Department of Surgery, Division of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, WI.
authors: Chelsea L
authors: CL
authors: Collins
authors: Peter J
authors: PJ
authors: Bartz
authors: David R
authors: DR
authors: Lal
authors: Annette D
authors: AD
authors: Segura
authors: Ronald K
authors: RK
authors: Woods
authors: Richard L
authors: RL
authors: Tower
mesh_terms: D000284:Administration, Oral; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D001706:Biopsy; D002648:Child; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D006338:Heart Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D012074:Remission Induction; D012509:Sarcoma / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide
references: J Heart Lung Transplant. 2002 Oct;21(10):1135-9
references: 12398881
references: Pediatr Blood Cancer. 2004 Apr;42(4):320-4
references: 14966827
references: J Thorac Oncol. 2010 Sep;5(9):1483-9
references: 20651614
references: J Clin Oncol. 2003 Mar 15;21(6):1074-81
references: 12637473
references: Am J Cardiol. 1996 Jan 1;77(1):107
references: 8540447
references: Br J Cancer. 1998 Dec;78(12):1624-8
references: 9862574
references: Ann Thorac Surg. 2011 Mar;91(3):770-6
references: 21352995
references: Cancer. 2008 Jun;112(11):2440-6
references: 18428209
references: Ann Surg Oncol. 2009 Dec;16(12):3358-65
references: 19830494
references: Ann Thorac Surg. 2008 Jun;85(6):2125-6
references: 18498840
references: J Thorac Cardiovasc Surg. 2009 Jun;137(6):1454-60
references: 19464464
references: Eur J Cancer. 1997 Oct;33(11):1816-22
references: 9470839
references: Curr Opin Cardiol. 2000 Mar;15(2):121-5
references: 10963150
references: Ann Thorac Surg. 1991 Jun;51(6):906-10
references: 2039319
references: Ann Thorac Surg. 2010 Jul;90(1):176-81
references: 20609770
references: Clin Orthop Relat Res. 2007 Jun;459:174-81
references: 17415009
references: J Thorac Cardiovasc Surg. 2002 Dec;124(6):1145-8
references: 12447180
references: Pediatr Blood Cancer. 2005 Jul;45(1):25-31
references: 15795880